University of Southern California Site Number : 8400004 — Los Angeles, California

University of Southern California Site Number : 8400004 is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Southern California Site Number : 8400004 has participated in 1 clinical trials.

Therapeutic areas: Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Sponsors: Bioverativ, a Sanofi company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Southern California Site Number : 8400004?

University of Southern California Site Number : 8400004 has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Southern California Site Number : 8400004 conducted?

University of Southern California Site Number : 8400004 has 1 clinical trials on record. Their work covers Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Is University of Southern California Site Number : 8400004 accredited by Crixeo Clinical Trials?

University of Southern California Site Number : 8400004 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Southern California Site Number : 8400004?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.